Mirabegron and Urinary Urgency Incontinence: The Clinical Response and the Female Urinary Microbiome
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 22 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2020.
- 08 Sep 2016 Status changed from active, no longer recruiting to recruiting.
- 15 Jul 2015 New trial record